Regulation and Function of T-Cell-Mediated Immunity during Toxoplasma gondii Infection
暂无分享,去创建一个
[1] S. Reed,et al. Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection , 1992, The Journal of experimental medicine.
[2] K. Sugane,et al. Antigen presentation by Toxoplasma gondii-infected cells to CD4+ proliferative T cells and CD8+ cytotoxic cells. , 1989, The Journal of parasitology.
[3] P. Allen,et al. Costimulation of T Cell Activation by Integrin-associated Protein (CD47) Is an Adhesion-dependent, CD28-independent Signaling Pathway , 1997, The Journal of experimental medicine.
[4] T. Gajewski,et al. Anti-proliferative effect of IFN-gamma in immune regulation. I. IFN-gamma inhibits the proliferation of Th2 but not Th1 murine helper T lymphocyte clones. , 1988, Journal of immunology.
[5] K. Joiner,et al. The parasitophorous vacuole membrane surrounding intracellular Toxoplasma gondii functions as a molecular sieve. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[6] S. Kaufmann,et al. Role of T cell subsets in immunity against intracellular bacteria: experimental infections of knock-out mice with Listeria monocytogenes and Mycobacterium bovis BCG. , 1994, Immunobiology.
[7] R. Tarleton,et al. Delivery by Trypanosoma cruzi of proteins into the MHC class I antigen processing and presentation pathway. , 1996, Journal of immunology.
[8] J. Dubremetz,et al. Subcellular localization of the 54-kDa antigen of Toxoplasma gondii. , 1993, The Journal of parasitology.
[9] G. Strickland,et al. Acquired resistance to infection with Schistosoma mansoni induced by Toxoplasma gondii , 1976, Nature.
[10] F. Derouin,et al. Protective effect of low doses of an anti‐IL‐4 monoclonal antibody in a murine model of acute toxoplasmosis , 1995, Parasite immunology.
[11] K. Joiner,et al. Toxoplasma gondii: fusion competence of parasitophorous vacuoles in Fc receptor-transfected fibroblasts. , 1990, Science.
[12] G. DosReis,et al. Programmed T-cell death in experimental chagas disease. , 1995, Parasitology today.
[13] J. Remington,et al. Immunity and Intracellular Infection: Resistance to Bacteria in Mice Infected with a Protozoan , 1968, Science.
[14] R. Coffman,et al. Lymphokine control of in vivo immunoglobulin isotype selection. , 1990, Annual review of immunology.
[15] H Hengartner,et al. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. , 1994, Science.
[16] A. Sher,et al. CD8+ T-cell interactions with Toxoplasma gondii: implications for processing of antigen for class-I-restricted recognition. , 1993, Research in immunology.
[17] A. Sher,et al. Genes for chemokines MuMig and Crg-2 are induced in protozoan and viral infections in response to IFN-gamma with patterns of tissue expression that suggest nonredundant roles in vivo. , 1996, Journal of immunology.
[18] H. Hisaeda,et al. Mechanisms of HSP65 expression induced by gamma delta T cells in murine Toxoplasma gondii infection. , 1996, Pathobiology : journal of immunopathology, molecular and cellular biology.
[19] T. Mosmann,et al. Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? , 1993, Immunology today.
[20] Y. Suzuki,et al. Impaired resistance to the development of toxoplasmic encephalitis in interleukin-6-deficient mice , 1997, Infection and immunity.
[21] I. Khan,et al. Production of nitric oxide (NO) is not essential for protection against acute Toxoplasma gondii infection in IRF-1-/- mice. , 1996, Journal of immunology.
[22] B. Schoel,et al. Phosphate is essential for stimulation of Vγ9Vδ2 T lymphocytes by mycobacterial low molecular weight ligand , 1994 .
[23] J. Dubremetz,et al. Antibody responses to Toxoplasma gondii in sera, intestinal secretions, and milk from orally infected mice and characterization of target antigens , 1990, Infection and immunity.
[24] I. Khan,et al. Antigen-specific CD8+ T cell clone protects against acute Toxoplasma gondii infection in mice. , 1994, Journal of immunology.
[25] R. Good,et al. Heat shock protein 65 induced by gammadelta T cells prevents apoptosis of macrophages and contributes to host defense in mice infected with Toxoplasma gondii. , 1997, Journal of immunology.
[26] C. Roberts,et al. Different roles for interleukin-4 during the course of Toxoplasma gondii infection , 1996, Infection and immunity.
[27] C. Roberts,et al. CD8+ T cells arethemajorlymphocyte subpopulation involved inthe protective immuneresponsetoToxoplasma gondii inmice , 1991 .
[28] D. Umetsu,et al. Antigen-driven but not lipopolysaccharide-driven IL-12 production in macrophages requires triggering of CD40. , 1997, Journal of immunology.
[29] S. Roncella,et al. An in vitro model for Toxoplasma infection in man. Interaction between CD4+ monoclonal T cells and macrophages results in killing of trophozoites. , 1988, Journal of immunology.
[30] M. Lenardo,et al. Induction of apoptosis in mature T cells by tumour necrosis factor , 1995, Nature.
[31] J. Orange,et al. IL-2-dependent NK cell responses discovered in virus-infected beta 2-microglobulin-deficient mice. , 1994, Journal of immunology.
[32] M. Kronenberg,et al. Mouse T lymphocytes that express a gamma delta T-cell antigen receptor contribute to resistance to Salmonella infection in vivo , 1994, Infection and immunity.
[33] A. Sher,et al. Infection of human immunodeficiency virus 1 transgenic mice with Toxoplasma gondii stimulates proviral transcription in macrophages in vivo , 1996, The Journal of experimental medicine.
[34] G. Trinchieri. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. , 1995, Annual review of immunology.
[35] E. Pfefferkorn. Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[36] A. Sher,et al. Host resistance to Toxoplasma gondii: model for studying the selective induction of cell-mediated immunity by intracellular parasites. , 1993, Infectious agents and disease.
[37] Y. Suzuki,et al. Toxoplasma antigens recognized by immunoglobulin G subclasses during acute and chronic infection , 1989, Journal of clinical microbiology.
[38] M. Caligiuri,et al. Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-gamma by natural killer cells in vitro. , 1995, The Journal of clinical investigation.
[39] C. Hunter,et al. Role of interleukin-10 in regulation of T-cell-dependent and T-cell-independent mechanisms of resistance to Toxoplasma gondii , 1997, Infection and immunity.
[40] P. Linsley,et al. The role of the CD28/B7 interaction in the regulation of NK cell responses during infection with Toxoplasma gondii. , 1997, Journal of immunology.
[41] E. Unanue,et al. Natural Immunity: A T‐Cell‐Independent Pathway of Macrophage Activation, Defined in the scid Mouse , 1991, Immunological reviews.
[42] S. Kyes,et al. Late dominance of the inflammatory process in murine influenza by gamma/delta + T cells , 1990, The Journal of experimental medicine.
[43] A. Sher,et al. Immunologic Control of Toxoplasma gondii Infection by CD8+ Lymphocytes: A Model for Class I MHC-Restricted Recognition of Intracellular Parasites , 1993 .
[44] J. Waring,et al. Immunodeficiency and Chronic Myelogenous Leukemia-like Syndrome in Mice with a Targeted Mutation of the ICSBP Gene , 1996, Cell.
[45] R. Schreiber,et al. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. , 1988, Science.
[46] J. Burke,et al. Temporal differences in the expression of mRNA for IL‐10 and IFN‐γ in the brains and spleens of C57BL/10 mice infected with Toxoplasma gondii , 1994, Parasite immunology.
[47] Y. Suzuki,et al. Gamma interferon induces Fas-dependent apoptosis of Peyer's patch T cells in mice following peroral infection with Toxoplasma gondii , 1997, Infection and immunity.
[48] O. Wiestler,et al. Expression pattern and cellular origin of cytokines in the normal and Toxoplasma gondii-infected murine brain. , 1997, The American journal of pathology.
[49] R. McLeod,et al. Phenotypes and functions of lymphocytes in congenital toxoplasmosis. , 1990, The Journal of laboratory and clinical medicine.
[50] A. Sher,et al. Bone marrow macrophages process exogenous Toxoplasma gondii polypeptides for recognition by parasite-specific cytolytic T lymphocytes. , 1993, Journal of immunology.
[51] M. de Carli,et al. Ability of HIV to promote a TH1 to TH0 shift and to replicate preferentially in TH2 and TH0 cells. , 1994, Science.
[52] C. Roberts,et al. Detection of cytokine mRNA in the brains of mice with toxoplasmic encephalitis , 1992, Parasite immunology.
[53] A. Fauci,et al. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. , 1993, Science.
[54] M. Sporn,et al. Deactivation of macrophages by transforming growth factor-beta. , 1988, Nature.
[55] S. Kaufmann,et al. Phosphate is essential for stimulation of V gamma 9V delta 2 T lymphocytes by mycobacterial low molecular weight ligand. , 1994, European journal of immunology.
[56] G. Trinchieri,et al. Interleukin 10 (IL-10) Inhibits Human Lymphocyte Interferon 3,-Production by Suppressing Natural Killer Cell Stimulatory Factor/IL-12 Synthesis in Accessory Cells By Annalisa D'Andrea, Miguel Aste-Amezaga, , 1993 .
[57] R. McLeod,et al. Class I MHC genes and CD8+ T cells determine cyst number in Toxoplasma gondii infection. , 1990, Journal of immunology.
[58] G. Grau,et al. Role of TNF and IL-1 in infections with Toxoplasma gondii. , 1990, Immunology.
[59] J. Boothroyd,et al. Antigen-specific (p30) mouse CD8+ T cells are cytotoxic against Toxoplasma gondii-infected peritoneal macrophages. , 1992, Journal of immunology.
[60] L. Johnson. A protective role for endogenous tumor necrosis factor in Toxoplasma gondii infection , 1992, Infection and immunity.
[61] T. Mosmann,et al. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones , 1989, The Journal of experimental medicine.
[62] Somesh D. Sharma,et al. Natural killer cells induced by acute and chronic toxoplasma infection. , 1982, Cellular immunology.
[63] R. Ahmed,et al. Molecular Pathways of CTL‐mediated Cytotoxicity , 1995, Immunological reviews.
[64] A. Sher,et al. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. , 1992, Journal of immunology.
[65] P. Overath,et al. Course of Leishmania infection in beta 2-microglobulin-deficient mice. , 1993, Immunology letters.
[66] C. Watts,et al. Capture and processing of exogenous antigens for presentation on MHC molecules. , 1997, Annual review of immunology.
[67] V. Nussenzweig,et al. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria , 1989, Nature.
[68] T. Curiel,et al. CD4-mediated and CD8-mediated cytotoxic and proliferative immune responses to Toxoplasma gondii in seropositive humans , 1996, Infection and immunity.
[69] E. Petricoin,et al. Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[70] G. Trinchieri,et al. The Interleukin 12 P40 Gene Promoter Is Primed by Interferon ~/in Monocytic Cells , 1996 .
[71] Hans Hengartner,et al. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice , 1994, Nature.
[72] P. Vassalli,et al. Monoclonal antibody against interferon gamma can prevent experimental cerebral malaria and its associated overproduction of tumor necrosis factor. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[73] J. K. Frenkel. Pathophysiology of toxoplasmosis. , 1988, Parasitology today.
[74] G. Trinchieri,et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes , 1989, Journal of Experimental Medicine.
[75] Giorgio,et al. Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells , 1992, The Journal of experimental medicine.
[76] A. Sher,et al. HIV infection suppresses type 1 lymphokine and IL-12 responses to Toxoplasma gondii but fails to inhibit the synthesis of other parasite-induced monokines. , 1995, Journal of immunology.
[77] L. Kasper,et al. Strain-specific antigens of Toxoplasma gondii , 1987, Infection and immunity.
[78] K. Rock,et al. Antigen processing and presentation by the class I major histocompatibility complex. , 1996, Annual review of immunology.
[79] R. McLeod,et al. Immunogenetics influence outcome of Toxoplasma gondii infection. , 1993, Research in immunology.
[80] T. Mosmann,et al. The role of IL-10 in crossregulation of TH1 and TH2 responses. , 1991, Immunology today.
[81] Y. Suzuki,et al. A gene(s) within the H-2D region determines the development of toxoplasmic encephalitis in mice. , 1991, Immunology.
[82] J. Remington,et al. Toxoplasmosis in the compromised host. , 1976, Annals of internal medicine.
[83] P. Overath,et al. Course of Leishmania infection in β2-microglobulin-deficient mice , 1993 .
[84] F. Araújo. Depletion of CD4+ T cells but not inhibition of the protective activity of IFN-gamma prevents cure of toxoplasmosis mediated by drug therapy in mice. , 1992, Journal of immunology.
[85] A. Sher,et al. CD8+ T cells from mice vaccinated against Toxoplasma gondii are cytotoxic for parasite-infected or antigen-pulsed host cells. , 1991, Journal of immunology.
[86] J. Remington,et al. Resistance to murine tumors conferred by chronic infection with intracellular protozoa, Toxoplasma gondii and Besnoitia jellisoni. , 1971, The Journal of infectious diseases.
[87] E. Denkers,et al. Toxoplasma gondii Triggers Granulocyte-Dependent Cytokine-Mediated Lethal Shock ind-Galactosamine-Sensitized Mice , 1998, Infection and Immunity.
[88] G. Guyatt,et al. Meta-analysis of prophylactic treatments against Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[89] Y. Suzuki,et al. Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4+ T cells in mice. , 1988, Journal of immunology.
[90] A. Weinberg,et al. IL-4 directs the development of Th2-like helper effectors. , 1990, Journal of immunology.
[91] J. Remington,et al. EFFECT OF NORMAL AND ACTIVATED HUMAN MACROPHAGES ON TOXOPLASMA GONDII , 1974, The Journal of experimental medicine.
[92] A. Sher,et al. Emergence of NK1.1+ cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii in MHC class I-deficient mice , 1993, The Journal of experimental medicine.
[93] A. Sher,et al. Opportunistic infections and retrovirus-induced immunodeficiency: studies of acute and chronic infections with Toxoplasma gondii in mice infected with LP-BM5 murine leukemia viruses , 1992, Infection and immunity.
[94] J. Remington,et al. Murine CD8+ cytotoxic T lymphocytes lyse Toxoplasma gondii-infected cells. , 1991, Journal of immunology.
[95] J. Berzofsky,et al. Cytotoxic T cells specific for the circumsporozoite protein of Plasmodium falciparum , 1988, Nature.
[96] J. Remington,et al. Toxoplasmosis: the time has come. , 1988, The New England journal of medicine.
[97] A. Sher,et al. Decreased resistance of TNF receptor p55- and p75-deficient mice to chronic toxoplasmosis despite normal activation of inducible nitric oxide synthase in vivo. , 1998, Journal of immunology.
[98] S. James. Role of nitric oxide in parasitic infections. , 1995, Microbiological reviews.
[99] R. Zinkernagel,et al. The roles of perforin‐ and Fas‐dependent cytotoxicity in protection against cytopathic and noncytopathic viruses , 1995, European journal of immunology.
[100] L. F. Fajardo,et al. Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria. , 1987, Science.
[101] J. Blackwell,et al. Influence of genes within the MHC on mortality and brain cyst development in mice infected with Toxoplasma gondii: kinetics of immune regulation in BALB H‐2 congenic mice , 1993, Parasite immunology.
[102] B. Navia,et al. Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: Clinical and neuropathological findings in 27 patients , 1986, Annals of neurology.
[103] J. K. Frenkel,et al. Toxoplasmosis in nude mice. , 1977, The Journal of parasitology.
[104] A. Sher,et al. Simultaneous depletion of CD4+ and CD8+ T lymphocytes is required to reactivate chronic infection with Toxoplasma gondii. , 1992, Journal of immunology.
[105] S. Tonegawa,et al. Gamma delta T cells contribute to immunity against the liver stages of malaria in alpha beta T-cell-deficient mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[106] T. Mosmann,et al. The role of IL-10 in crossregulation of TH1 and TH2 responses. , 1991 .
[107] A. Sher,et al. Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[108] R. S. Williams,et al. Functional heterogeneity of mammalian TATA-box sequences revealed by interaction with a cell-specific enhancer , 1990, Nature.
[109] R. Ueda,et al. Immune function in mice lacking the perforin gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[110] J. K. Frenkel. Adoptive immunity to intracellular infection. , 1967, Journal of immunology.
[111] Y. Yoshikai,et al. Sequential appearance of γ/δ‐ and α/β‐bearing T cells in the peritoneal cavity during an i.p. infection with Listeria monocytogenes , 1990 .
[112] C. Hunter,et al. Immunocytochemical detection of cytokines in the lymph nodes and brains of mice resistant or susceptible to toxoplasmic encephalitis. , 1994, The Journal of infectious diseases.
[113] J. Remington,et al. Antibody responses to toxoplasma antigens in mice infected with strains of different virulence , 1980, Infection and immunity.
[114] S. Landolfo,et al. Monoclonal antibody against IFN-gamma inhibits Moloney murine sarcoma virus-specific cytotoxic T lymphocyte differentiation. , 1988, Journal of immunology.
[115] B. Bloom,et al. Natural and synthetic non-peptide antigens recognized by human γδ T cells , 1995, Nature.
[116] H. Murray,et al. Role of tryptophan degradation in respiratory burst-independent antimicrobial activity of gamma interferon-stimulated human macrophages , 1989, Infection and immunity.
[117] A. Sher,et al. In Vivo Microbial Stimulation Induces Rapid CD40 Ligand–independent Production of Interleukin 12 by Dendritic Cells and their Redistribution to T Cell Areas , 1997, The Journal of experimental medicine.
[118] K. Takeshita,et al. Human V delta 2+ gamma delta T-cell tolerance to foreign antigens of Toxoplasma gondii. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[119] R. Coffman,et al. Regulation of immunity to parasites by T cells and T cell-derived cytokines. , 1992, Annual review of immunology.
[120] A. Sher,et al. Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. , 1991, Journal of immunology.
[121] H. Murray,et al. L-arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes. , 1992, The Journal of infectious diseases.
[122] A. Sher,et al. Role of macrophage-derived cytokines in the induction and regulation of cell-mediated immunity to Toxoplasma gondii. , 1996, Current topics in microbiology and immunology.
[123] A. Sher,et al. Toxoplasma gondii possesses a superantigen activity that selectively expands murine T cell receptor V beta 5-bearing CD8+ lymphocytes , 1994, The Journal of experimental medicine.
[124] A. Sher,et al. Production of IL-10 by CD4+ T lymphocytes correlates with down-regulation of Th1 cytokine synthesis in helminth infection. , 1991, Journal of immunology.
[125] A. Sher,et al. Toxoplasma gondii soluble products induce cytokine secretion by macrophages and potentiate in vitro replication of a monotropic strain of HIV. , 1994, The Journal of eukaryotic microbiology.
[126] G. Stryker,et al. Isolation from Trypanosoma cruzi-infected mice of CD8+, MHC-restricted cytotoxic T cells that lyse parasite-infected target cells. , 1993, Journal of immunology.
[127] I. Khan,et al. Activation-mediated CD4+ T cell unresponsiveness during acute Toxoplasma gondii infection in mice. , 1996, International immunology.
[128] M. Demitrack,et al. Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease. , 1992, Brain : a journal of neurology.
[129] R. de Waal Malefyt,et al. Alpha beta T cell response to Toxoplasma gondii in previously unexposed individuals. , 1998, Journal of immunology.
[130] M. Caligiuri,et al. Ultra low dose interleukin-2 therapy promotes a type 1 cytokine profile in vivo in patients with AIDS and AIDS-associated malignancies. , 1998, The Journal of clinical investigation.
[131] A. Sher,et al. In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. , 1996, Journal of immunology.
[132] Y. Ito,et al. Gamma delta T cells play an important role in hsp65 expression and in acquiring protective immune responses against infection with Toxoplasma gondii. , 1995, Journal of immunology.
[133] L. Sibley,et al. Intracellular fate of vacuoles containing Toxoplasma gondii is determined at the time of formation and depends on the mechanism of entry. , 1997, Journal of immunology.
[134] M. Bonneville,et al. Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands. , 1994, Science.
[135] R. Seder,et al. Differential roles for IL-12 in the maintenance of immune responses in infectious versus autoimmune disease. , 1996, Journal of immunology.
[136] R. McLeod,et al. Genetic regulation of early survival and cyst number after peroral Toxoplasma gondii infection of A x B/B x A recombinant inbred and B10 congenic mice. , 1989, Journal of immunology.
[137] C. Hunter,et al. Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha , 1994, Infection and immunity.
[138] J. K. Frenkel,et al. Specific and nonspecific mediation of protective immunity to Toxoplasma gondii , 1987, Infection and immunity.
[139] S. Tonegawa,et al. Different roles of αβ and γδ T cells in immunity against an intracellular bacterial pathogen , 1993, Nature.
[140] A. Sher,et al. Perforin-mediated cytolysis plays a limited role in host resistance to Toxoplasma gondii. , 1997, Journal of immunology.
[141] J. Montoya,et al. Human CD4+ and CD8+ T lymphocytes are both cytotoxic to Toxoplasma gondii-infected cells , 1996, Infection and immunity.
[142] A. Sher,et al. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[143] J. Schwartzman,et al. A dichotomous role for nitric oxide during acute Toxoplasma gondii infection in mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[144] J. Montoya,et al. Evidence for genetic regulation of susceptibility to toxoplasmic encephalitis in AIDS patients. , 1996, The Journal of infectious diseases.
[145] J. Remington,et al. Unexposed Individuals in Toxoplasma gondii T Cell Response to βα , 1998 .
[146] R. Nussenblatt,et al. Toxoplasma gondii: Acquired Ocular Toxoplasmosis in the Murine Model, Protective Role of TNF-α and IFN-γ , 1994 .
[147] Y. Suzuki,et al. Treatment with anti-L3T4 (CD4) monoclonal antibody reduces the inflammatory response in toxoplasmic encephalitis. , 1989, Journal of immunology.
[148] Z. Brener,et al. Protective effects of specific antibodies in Trypanosoma cruzi infections. , 1976, Journal of immunology.
[149] V. Tsai,et al. Acute toxoplasma infection of mice induces spleen NK cells that are cytotoxic for T. gondii in vitro. , 1986, Journal of immunology.
[150] A. Sher,et al. IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity. , 1992, Journal of immunology.
[151] A. Sher,et al. A Role for Cd4+nki.1 + T Lymphocytes as Major Histocompatibility Complex Class Ii Independent Helper Cells in the Generation of Cd8 + Effector Function against Intracellular Infection , 1996 .
[152] C. Hunter,et al. Transforming growth factor‐β inhibits interleukin‐12‐induced production of interferon‐γ by natural killer cells: A role for transforming growth factor‐β in the regulation of T cell‐independent resistance to Toxoplasma gondii , 1995 .
[153] K. Murphy,et al. Through an Nf-kappa B Half-site. Regulation of Interleukin 12 P40 Expression , 1995 .
[154] G. Trinchieri,et al. Neutrophil production of IL-12 and IL-10 in candidiasis and efficacy of IL-12 therapy in neutropenic mice. , 1997, Journal of immunology.
[155] Qing Yang,et al. MHC class I gene(s) in the D/L region but not the TNF-alpha gene determines development of toxoplasmic encephalitis in mice. , 1994, Journal of immunology.
[156] P. Cresswell. Antigen Presentation: Getting peptides into MHC class II molecules , 1994, Current Biology.
[157] A. Sher,et al. Toxoplasma gondii: evidence for interleukin-12-dependent and-independent pathways of interferon-gamma production induced by an attenuated parasite strain. , 1996, Experimental parasitology.
[158] M. Sporn,et al. Deactivation of macrophages by transforming growth factor-β , 1988, Nature.
[159] C. Hunter,et al. Cytokine mRNA in the central nervous system of SCID mice infected with Toxoplasma gondii: importance of T-cell-independent regulation of resistance to T. gondii , 1993, Infection and immunity.
[160] A. Sher,et al. Induction and regulation of host cell-mediated immunity by Toxoplasma gondii. , 1995, Ciba Foundation symposium.
[161] C. Hsieh,et al. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. , 1993, Science.
[162] Y. Ito,et al. Induction of heat shock protein closely correlates with protection against Toxoplasma gondii infection. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[163] T. Curiel,et al. Cloned human CD4+ cytotoxic T lymphocytes specific for Toxoplasma gondii lyse tachyzoite-infected target cells. , 1993, Journal of immunology.
[164] Y. Suzuki,et al. Association of CD4+ T cell-dependent, interferon-gamma-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii , 1996, The Journal of experimental medicine.
[165] A. Sher,et al. The microbicidal activity of interferon‐γ‐treated macrophages against Trypanosoma cruzi involves an L‐arginine‐dependent, nitrogen oxide‐mediated mechanism inhibitable by interleukin‐10 and transforming growth factor‐β , 1992, European journal of immunology.
[166] C. Hunter,et al. IL-1 beta is required for IL-12 to induce production of IFN-gamma by NK cells. A role for IL-1 beta in the T cell-independent mechanism of resistance against intracellular pathogens. , 1995, Journal of immunology.
[167] A. Sher,et al. Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-alpha and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation. , 1993, Journal of immunology.
[168] Y. Chien,et al. RECOGNITION BY / T CELLS , 1996 .
[169] I. Khan,et al. Induction of gammadelta T cells during acute murine infection with Toxoplasma gondii. , 1996, Journal of immunology.
[170] R. Saavedra,et al. Human T cell clone identifies a potentially protective 54-kDa protein antigen of Toxoplasma gondii cloned and expressed in Escherichia coli. , 1991, Journal of immunology.
[171] R. Gazzinelli,et al. Contribution of nitric oxide to the host parasite equilibrium in toxoplasmosis. , 1996, Journal of immunology.
[172] H. Macdonald,et al. A role for gamma delta + T cells during experimental infection of mice with Leishmania major. , 1993, Journal of immunology.
[173] R. Gazzinelli,et al. Effects of IL-12 on immune responses to microbial infections: a key mediator in regulating disease outcome. , 1995, Current opinion in immunology.
[174] J. Klein,et al. Infectious Diseases of the Fetus and Newborn Infant , 1983 .
[175] C. Hunter,et al. Studies on the role of interleukin-12 in acute murine toxoplasmosis. , 1995, Immunology.
[176] A. Sher,et al. In the absence of endogenous IFN-gamma, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. , 1996, Journal of immunology.
[177] Y. Suzuki,et al. The effect of anti-IFN-gamma antibody on the protective effect of Lyt-2+ immune T cells against toxoplasmosis in mice. , 1990, Journal of immunology.
[178] F. Aosai,et al. Isolation of naturally processed peptides from a Toxoplasma gondii-infected human B lymphoma cell line that are recognized by cytotoxic T lymphocytes. , 1994, Journal of Parasitology.
[179] J. Tschopp,et al. Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways , 1994, Nature.
[180] W. Fiers,et al. The p38/RK mitogen‐activated protein kinase pathway regulates interleukin‐6 synthesis response to tumor necrosis factor. , 1996, The EMBO journal.
[181] A. Sher,et al. Toxoplasma gondii induces a T-independent IFN-gamma response in natural killer cells that requires both adherent accessory cells and tumor necrosis factor-alpha. , 1993, Journal of immunology.
[182] R. Locksley,et al. Oxygen‐dependent microbicidal systems of phagocytes and host defense against intracellular protozoa , 1983, Journal of cellular biochemistry.
[183] S. Reed,et al. Regulation of Trypanosoma cruzi infections in vitro and in vivo by transforming growth factor beta (TGF-beta) , 1991, The Journal of experimental medicine.
[184] A. Sher,et al. Parasite-induced IL-12 stimulates early IFN-gamma synthesis and resistance during acute infection with Toxoplasma gondii. , 1994, Journal of immunology.
[185] I. Khan,et al. A purified parasite antigen (p30) mediates CD8+ T cell immunity against fatal Toxoplasma gondii infection in mice. , 1991, Journal of immunology.
[186] S. Szabo,et al. Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4 , 1995, The Journal of experimental medicine.
[187] J. Lucet,et al. Septic shock due to toxoplasmosis in patients infected with the human immunodeficiency virus. , 1993, Chest.
[188] W. O'brien,et al. Cytokines alter production of HIV-1 from primary mononuclear phagocytes. , 1988, Science.
[189] Y. Tanaka,et al. Natural and synthetic non-peptide antigens recognized by human gamma delta T cells. , 1995, Nature.
[190] G. Trinchieri,et al. The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells , 1996, The Journal of experimental medicine.
[191] J. Heesemann,et al. Reduced replication of Toxoplasma gondii is necessary for induction of bradyzoite-specific antigens: a possible role for nitric oxide in triggering stage conversion , 1994, Infection and immunity.
[192] W. Paul,et al. Cultured NK1.1+ CD4+ T cells produce large amounts of IL-4 and IFN-gamma upon activation by anti-CD3 or CD1. , 1997, Journal of immunology.
[193] O. Janssen,et al. The primary response of human gamma/delta + T cells to Mycobacterium tuberculosis is restricted to V gamma 9-bearing cells , 1991, The Journal of experimental medicine.
[194] R. Flavell,et al. Dissection of the interferon gamma‐MHC class II signal transduction pathway reveals that type I and type II interferon systems share common signalling component(s). , 1992, The EMBO journal.
[195] C. Maliszewski,et al. Activated T cells induce interleukin‐12 production by monocytes via CD40‐CD40 ligand interaction , 1995, European journal of immunology.
[196] E. Chi,et al. Toxoplasma gondii alters eicosanoid release by human mononuclear phagocytes: role of leukotrienes in interferon gamma-induced antitoxoplasma activity , 1994, The Journal of experimental medicine.
[197] G. Trinchieri,et al. Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma- production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells , 1993, The Journal of experimental medicine.
[198] C. Nathan,et al. Activation of macrophages in vivo and in vitro. Correlation between hydrogen peroxide release and killing of Trypanosoma cruzi , 1979, The Journal of experimental medicine.
[199] R. Nussenblatt,et al. An unusually high prevalence of ocular toxoplasmosis in southern Brazil. , 1992, American journal of ophthalmology.
[200] S. Reed,et al. Transforming growth factor-beta in leishmanial infection: a parasite escape mechanism. , 1992, Science.
[201] J. Berzofsky,et al. Role of T‐Cell Derived Cytokines in the Downregulation of Immune Responses in Parasitic and Retroviral Infection , 1992, Immunological reviews.
[202] W. Paul,et al. Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis , 1995, Molecular and cellular biology.
[203] J. Montoya,et al. Preferential activation and expansion of human peripheral blood gamma delta T cells in response to Toxoplasma gondii in vitro and their cytokine production and cytotoxic activity against T. gondii-infected cells. , 1995, The Journal of clinical investigation.
[204] W. AptB. Toxoplasmosis in developing countries. , 1985 .
[205] J. Justement,et al. Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[206] H. Kretzschmar,et al. Cellular composition and distribution of gliomesenchymal nodules in the CNS of AIDS patients. , 1993, Clinical neuropathology.
[207] Y. Suzuki,et al. Treatment of toxoplasmic encephalitis in mice with recombinant gamma interferon , 1990, Infection and Immunity.
[208] E. Podack. Execution and suicide: cytotoxic lymphocytes enforce Draconian laws through separate molecular pathways. , 1995, Current opinion in immunology.
[209] S. Park,et al. Mouse CD1-specific NK1 T cells: development, specificity, and function. , 1997, Annual review of immunology.
[210] L. Sibley,et al. Genetic basis of pathogenicity in toxoplasmosis. , 1996, Current topics in microbiology and immunology.
[211] D. Bout,et al. Adoptive transfer of gut intraepithelial lymphocytes protects against murine infection with Toxoplasma gondii. , 1997, Journal of immunology.
[212] B. Luft,et al. Functional and quantitative alterations in T lymphocyte subpopulations in acute toxoplasmosis. , 1984, The Journal of infectious diseases.
[213] D. Bout,et al. Toxoplasma gondii oral infection induces specific cytotoxic CD8 alpha/beta+ Thy-1+ gut intraepithelial lymphocytes, lytic for parasite-infected enterocytes. , 1994, Journal of immunology.
[214] Y. Chien,et al. Recognition by gamma/delta T cells. , 1996, Annual review of immunology.
[215] A. Sher,et al. Inducible Nitric Oxide Is Essential for Host Control of Persistent but Not Acute Infection with the Intracellular Pathogen Toxoplasma gondii , 1997, The Journal of experimental medicine.
[216] R. Gerli,et al. Lymphocytes bearing the gamma delta T-cell receptor in acute toxoplasmosis. , 1992, Immunology.
[217] T. Mosmann,et al. IL-10 inhibits cytokine production by activated macrophages. , 1991, Journal of immunology.
[218] Y. Suzuki,et al. Importance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice. , 1989, Journal of immunology.
[219] P. Hohlfeld,et al. Toxoplasma gondii infection during pregnancy: T lymphocyte subpopulations in mothers and fetuses , 1990, The Pediatric infectious disease journal.
[220] A. Sher,et al. Critical roles for the Bcl-3 oncoprotein in T cell-mediated immunity, splenic microarchitecture, and germinal center reactions. , 1997, Immunity.
[221] K. Murphy,et al. Regulation of interleukin 12 p40 expression through an NF-kappa B half-site , 1995, Molecular and cellular biology.
[222] M. Zajdowicz,et al. Infectious Diseases of the Fetus and Newborn Infant , 1995 .
[223] B. Luft,et al. Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome. , 1984, JAMA.
[224] D. Cooper,et al. Low-Dose Trimethoprim-Sulfamethoxazole Prophylaxis for Toxoplasmic Encephalitis in Patients with AIDS , 1992, Annals of Internal Medicine.
[225] C. Hunter,et al. Mitogen- and antigen-specific proliferation of T cells in murine toxoplasmosis is inhibited by reactive nitrogen intermediates , 1994, Infection and immunity.
[226] R. McLeod,et al. Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis. , 1995, Immunology.
[227] A. Bollen,et al. Epitopes recognized by human T lymphocytes in the ROP2 protein antigen of Toxoplasma gondii , 1996, Infection and immunity.
[228] C. Turck,et al. Targeted activation of CD8 cells and infection of beta 2-microglobulin-deficient mice fail to confirm a primary protective role for CD8 cells in experimental leishmaniasis. , 1993, Journal of immunology.
[229] A. Sher,et al. Interferon Consensus Sequence Binding Protein–deficient Mice Display Impaired Resistance to Intracellular Infection Due to a Primary Defect in Interleukin 12 p40 Induction , 1997, The Journal of experimental medicine.
[230] C. Roberts,et al. Kinetics of cytokine mRNA production in the brains of mice with progressive toxoplasmic encephalitis , 1992, European journal of immunology.
[231] W. Paul,et al. Generation of interleukin 4 (IL-4)-producing cells in vivo and in vitro: IL-2 and IL-4 are required for in vitro generation of IL-4- producing cells , 1990, The Journal of experimental medicine.
[232] W. Henderson,et al. Alteration of leukotriene release by macrophages ingesting Toxoplasma gondii. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[233] Jerry L. Adams,et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis , 1994, Nature.